Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1959-1964

  Kim, Seung Ju ^a   Kim, Weon ^b   Kim, Jong Bum ^a   Hong, Myung Ju ^a   Kang, Won Yu ^a   Hwang, Sun Ho ^a   Kim, Wan ^a  

^a Cardiovascular Center of Gwangju Veterans Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Critical limb ischemia; Patency; Peripheral vascular disease; Subintimal angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL ARTERY DISEASE; GRAFT PATENCY; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE PERIOD; PREDICTION; PROSTHESIS FAILURE; STENT; SUPERFICIAL FEMORAL ARTERY;

AGED; ANGIOPLASTY; EXTREMITIES; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROGNOSIS; VASCULAR PATENCY;

EID: 77956119828     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0106     Document Type: Article

References (26)

1. London NJ, Srinivasan R, Naylor AR, Hartshorene T, Rafliff DA, Bell PR, et al. Subintimal angioplasty of femoropopliteal artery occlusion: The long term results. Eur J Vasc Endovasc Surg 1994; 8: 148-155.
2. Nyhahl S, Hartshorene T, Bell PR, Bolia A, London NJ. Subintimal angioplasty of infrapopliteal occlusions in critically ischaemic limbs. Eur J Vasc Endovasc Surg 1997; 14: 212-216.
3. Laxdal E, Jenssens GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg 2003; 25: 578-582.
4. Bolia A. Percutaneous intentional extraluminal (subintimal) recanalization of crural arteries. Eur J Radiol 1998; 28: 199-204.
5. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: Factors influencing long term success. Circulation 1991; 83(Suppl): 170-180.
6. Vraux H, Hammer F, Verhelst R, Goffette P, Vandeleene B. Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischemia: Mid-term results. Eur J Vasc Endovasc Surg 2000; 20: 441-446.
7. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997; 26: 517-538.
8. Rutherford RB, Jones DN, Bergentz SE, Bergqvist D, Comerota AJ, Dardik H, et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988; 8: 236-246.
9. Management of peripheral arterial disease: Trans-Atlantic Inter- Society Consensus (TASC). J Vasc Surg 2000; 31(Suppl): S1-S250.
10. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(Suppl): 5-67.
11. Reekers JA, Bolia A. Percutaneous intentional extraluminal (subintimal) recanalization: How to do it yourself. Eur J Radiol 1998; 28: 192-198.
12. Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-315.
13. Nasim A, Sayers RD, Dunlop P, Bell PR, Bolia A. Intentional extraluminal recanalization of the femoropopliteal segment following perforation during percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 1996; 12: 246-249.
14. Shaw MB, DeNunzio M, Hinwood D, Nash R, Callum KG, Braithwaite BD. The results of subintimal angioplasty in a district general hospital. Eur J Vasc Endovasc Surg 2002; 24: 524-527.
15. Scott EC, Biuckians A, Light RE, Scibelli CD, Milner TP, Meier GH 3rd, et al. Subintimal angioplasty for the treatment of claudication and critical limb ischemia: 3-year results. J Vasc Surg 2007; 46: 959-964.
16. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, et al. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoro-popliteal artery lesions: 4 years' experience. Circ J 2009; 73: 2143-2147.
17. McCarthy RJ, Neary W, Roobottom C, Tottle A, Ashley S. Shortterm results of femoropopliteal subintimal angioplasty. Br J Surg 2000; 87: 1361-1365.
18. Yilmaz S, Sindel T, Ceken K, Alimoǧlu E, Lüleci E. Subintimal recanalization of long superficial femoral artery occlusions through the retrograde popliteal approach. Cardiovasc Intervent Radiol 2001; 24: 154-160.
19. Yilmaz S, Sindel T, Uegin A, Luleci E. Subintimal angioplasty of long superficial femoral artery occlusion. J Vasc Intervent Radiol 2003; 14: 997-1010.
20. Smith BM, Stechman M, Gibson M, Torrie EP, Magee TR, Galland RB. Subintimal angioplasty for superficial femoral artery occlusion: Poor patency in critical ischaemia. Ann R Coll Surg Engl 2005; 87: 361-365.
21. Bown MJ, Bolia A, Sutton AJ. Subintimal angioplasty: Metaanalytical evidence of clinical utility. Eur J Vasc Endovasc Surg 2009; 38: 323-337.
22. Setacci C, Chisci E, de Donato G, Setacci F, Iacoponi F, Galzerano G. Subintimal angioplasty with aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg 2009; 38: 76-87.
23. Lazaris AM, Salas C, Tsiamis AC, Vlachou PA, Bolia A, Fishwick G. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg 2006; 32: 668-674.
24. Antusevas A, Aleksynas N, Kaupas RS, Inciura D, Kinduris S. Comparison of results of subintimal angioplasty and percutaneous transluminal angioplasty in superficial femoral artery occlusions. Eur J Vasc Endovasc Surg 2008; 36: 101-106.
25. Kamiya C, Sakamoto S, Tamori Y, Yoshimuta T, Higashi M, Tanaka R, et al. Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease. Circ J 2008; 72: 734-739.
26. Iida O, Nanto S, Uematsu M, Morozumi T, Kotani J, Awata M, et al. Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J 2005; 69: 1256-1259.